Launching Digital Validation: MilliporeSigma's 97-Day Implementation Success Story
By Lisa Weeks, Marketing Director, ValGenesis

Efficiency and compliance are paramount in the life sciences industry. However, outdated paper-based validation processes can jeopardize both, leading to inefficiencies and potential compliance issues. MilliporeSigma, the life sciences division of Merck KGaA in the U.S. and Canada, recognized the need for a more efficient and reliable method to manage their validation activities. To address this, they adopted ValGenesis VLMS, a cutting-edge digital validation management system. The transition to digital validation at MilliporeSigma's Carlsbad site was remarkably swift, taking just 97 days. This rapid implementation significantly reduced manual effort, streamlined validation processes, and accelerated the return on investment (ROI). The move to ValGenesis VLMS not only enhanced operational efficiency but also ensured compliance with regulatory standards.
Delve into the key takeaways from MilliporeSigma's implementation journey by accessing the full case study.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.